Skeletal Modifications of $$\upbeta $$ Β -Carboline Alkaloids and Their Antiviral Activity Profile

Yan Yang,Yuanqiong Huang,Hongjian Song,Yuxiu Liu,Lizhong Wang,Qingmin Wang
DOI: https://doi.org/10.1007/s11030-016-9669-8
2016-01-01
Molecular Diversity
Abstract:To study the effect of the variation of fused ring size and substitution on the antiviral activity of \(\upbeta \)-carboline alkaloids, four types of structurally novel \(\upbeta \)-carboline alkaloids analogues, with indole-fused six- to nine-membered-rings motifs, were designed, synthesized, and evaluated for the inhibition of tobacco mosaic virus (TMV). Bioassay results indicated that most of these analogues had significant anti-TMV activity; especially I-14 (54 \(\pm \) 3 % at 500 \(\upmu \)g/mL in vitro; 51 \(\pm \) 2, 45 \(\pm \) 2, and 42 \(\pm \) 1 % at 500 \(\upmu \)g/mL in vivo), II-4 (53 \(\pm \) 1 % at 500 \(\upmu \)g/mL in vitro; 49 \(\pm \) 2, 57 \(\pm \) 2, and 48 \(\pm \) 1 % at 500 \(\upmu \)g/mL in vivo), and II-8 (48 \(\pm \) 1 % at 500 \(\upmu \)g/mL in vitro; 53 \(\pm \) 2 %, 56 \(\pm \) 2 %, and 46 \(\pm \) 1 % at 500 \(\upmu \)g/mL in vivo), which were more potent vs. TMV than was ribavirin (36 \(\pm \) 1 % at 500 \(\upmu \)g/mL in vitro; 37 \(\pm \) 2, 41 \(\pm \) 2, and 38 \(\pm \) 1 % at 500 \(\upmu \)g/mL in vivo). The size of the fused ring has important effects on anti-TMV potency, which may be ascribed to conformational differences. The X-ray structures of I-1, I-6, II-8, and III show differing conformational preferences. The most potent compounds can be used as leads for further optimization as antiphytoviral agents.
What problem does this paper attempt to address?